Harry said he was “very excited” to find a new job

Just when the people who eat melons were still talking about the Harry and his wife’s revelations on the Oprah talk show, Harry suddenly announced on the 23rd that he had found a new job – serving as the chief influence officer of a start-up company in Silicon Valley in the United States.

CNN said on the 23rd that Harry’s upcoming company is called BetterUp, headquartered in San Francisco, and is a start-up company that specializes in providing psychological counseling and counseling to customers. The company’s customers include the National Aeronautics and Space Administration (NASA), Mars, Hilton Hotels and Chevron. BetterUp’s website has listed Harry as a member of the leadership team and called him a “humanitarian, veteran, mental health advocate, and environmentalist”.

Harry said in a statement that he is “very excited” about this new role and that his goal in his new role is to “open a critical dialogue around mental health and build a supportive and compassionate community.” According to reports, the position of “influence officer” is relatively rare in the corporate world. At present, Harry’s specific responsibilities, working hours, and salary are unclear. However, a source revealed that Harry’s annual income for this job may be as high as 7 digits.

According to the report, Harry will mainly participate in BetterUp’s product strategic decision-making and charitable donations, and will openly advocate topics related to mental health. Better-Up CEO Alexis Robbie Jocks said in an interview with The Wall Street Journal: “This is a very meaningful role.” Harry said that he joined BetterUp mainly because he saw BetterUp’s determination to help people solve psychological problems. As BetterUp’s first chief impact officer, Harry will promote dialogue on mental health and help people build confidence.

EU tightens exports of COVID-19 vaccine

“The battle for vaccines in the European Union is getting fiercer!” German “Der Spiegel” reported on the 24th that the European Union announced on Wednesday a stricter new crown vaccine export control regulations to prevent vaccine manufacturers in the European Union from receiving higher vaccination rates in the UK. High countries export new crown vaccines.

According to the new regulations, any COVID-19 vaccine manufacturer in Europe that exports COVID-19 vaccine to other countries must obtain a license from the European Union. The export ban applies to all vaccines produced in the European Union, including vaccines produced by AstraZeneca, Pfizer and Modena. As the EU’s largest exporter of vaccines, the United Kingdom is bound to be most affected, and it will also have a greater impact on countries such as Canada and Israel.

The EU made this provision because EU member states are currently in the third wave of epidemics, many countries lack vaccines, epidemic prevention measures are becoming more and more stringent, and the public’s criticism of the government is also increasing. In response, EU health director Galina stated in the European Parliament on Tuesday that the EU will use “all possible means” to obtain the AstraZeneca vaccine. She criticized only one of AstraZeneca’s five production bases for supplying vaccines to the European Union, “this is a shame.”

AstraZeneca has unilaterally and drastically reduced the delivery of vaccines to the European Union several times before: only 30 million doses of vaccine were provided in the first quarter instead of the 120 million doses in the contract; 30 million doses of vaccine were provided in the second quarter. Not the 180 million doses of vaccine in the contract. Deutsche News Agency also reported on the 24th that AstraZeneca has also stored 29 million doses of the new crown vaccine in Italy, ready to be exported to the UK. The EU has now intervened in an investigation and may ban its exports.

According to the report, the new vaccine export ban proposed by European Commission President von der Lein is mainly aimed at the United States and the United Kingdom. So far, almost no vaccines have been exported from the United States and the United Kingdom. The vaccination rates of the two countries are also far ahead of the EU countries. German Chancellor Merkel expressed support for the ban on the 23rd. Although many people in Europe believe that the AstraZeneca vaccine is not safe, the European Commission and member states continue to promote AstraZeneca vaccination in order to avoid an increase in the epidemic due to the lack of vaccines.